Intrinsic Value

The intrinsic value of Siriuspoint Ltd (3XPA) under the Base Case is 30.14 EUR per share. Compared with the current market price of 23.4 EUR, the stock appears Undervalued by 22% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

3XPA Intrinsic Value
€30.14
Undervaluation 22%
Intrinsic Value
Price €23.4

3XPA is valued in line with its history. A discount of this size has been typical over the past 5 years.

Alert me when 3XPA is below its intrinsic value
Today €21.10 · 9.8% below the current price
Alternatives to 3XPA

Fundamental Analysis

What Siriuspoint Does

Insurance Financials

SiriusPoint Ltd is a global specialty insurer and reinsurer. It takes on risks that are too specific, complex, or large for standard insurance products, such as property, casualty, accident, and other specialty lines. The company sells coverage mainly through brokers, managing general agents, and other insurance partners rather than directly to consumers.

Headquarters
Bermuda BM
Employees
1 099
IPO date
Aug 15, 2013
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q3 2026 · November 6, 2026

SiriusPoint paired a strong quarter with a RiverStone loss portfolio transfer to reduce legacy uncertainty and a reporting shift toward its specialty underwriting business.

Open the earnings call
EPS
$0.88
Expected
$0.61
Surprise
+44.3%
Stock, day of the call
+0.2%
View Earnings Call

Past 12 months

Continue 3XPA Research

Decided on Siriuspoint? Get an email when 3XPA reaches the price you’d buy at. Free with an account.

Other Siriuspoint listings

What is the Intrinsic Value of one 3XPA stock?

The intrinsic value for Siriuspoint Ltd (3XPA) under the Base Case is 30.14 EUR.

Is 3XPA stock undervalued or overvalued?

Compared with the current market price of 23.4 EUR, the stock appears Undervalued by 22% .

How reliable are our estimates? See how past valuations played out
Back to Top